We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals
SNDX

160 hedge funds and large institutions have $1.78B invested in Syndax Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 65 increasing their positions, 41 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 10

59% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 41

28% more capital invested

Capital invested by funds: $1.39B → $1.78B (+$393M)

15% more funds holding

Funds holding: 139 → 160 (+21)

10% more funds holding in top 10

Funds holding in top 10: 10 → 11 (+1)

8% more call options, than puts

Call options by funds: $2.77M | Put options by funds: $2.56M

0.59% more ownership

Funds ownership: 105.87% → 106.47% (+0.59%)

Holders
160
Holders Change
+21
Holders Change %
+15.11%
% of All Funds
2.57%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.18%
New
32
Increased
65
Reduced
41
Closed
10
Calls
$2.77M
Puts
$2.56M
Net Calls
+$203K
Net Calls Change
-$4.79M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$83.9M
2
State Street
State Street
Massachusetts
+$24M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$21.5M
4
PBA
Paradigm Biocapital Advisors
New York
+$20.3M
5
Barclays
Barclays
United Kingdom
+$16M

Top Sellers

1
WP
Woodline Partners
California
-$19M
2
HM
HealthCor Management
New York
-$18.4M
3
6CM
683 Capital Management
New York
-$13.1M
4
NCM
Nantahala Capital Management
Connecticut
-$9.32M
5
BI
BVF Inc
California
-$8.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
101
Bayesian Capital Management
New York
$518K +$221K +9,487 +87%
Invesco
102
Invesco
Georgia
$513K -$1.31M -56,244 -74%
HS
103
HighVista Strategies
Massachusetts
$475K -$430K -18,443 -50%
Jane Street
104
Jane Street
New York
$475K +$435K +18,660 New
Tudor Investment Corp
105
Tudor Investment Corp
Connecticut
$422K +$387K +16,581 New
Allianz Asset Management
106
Allianz Asset Management
Germany
$407K – – –
Teacher Retirement System of Texas
107
Teacher Retirement System of Texas
Texas
$394K -$6.39K -274 -2%
SEI Investments
108
SEI Investments
Pennsylvania
$388K -$18.3K -785 -5%
PWP
109
Principle Wealth Partners
Connecticut
$382K +$350K +15,000 New
FAM
110
Fred Alger Management
New York
$381K +$31.7K +1,359 +10%
EFM
111
E Fund Management
China
$353K +$88.6K +3,799 +38%
ASRS
112
Arizona State Retirement System
Arizona
$345K +$13.5K +578 +4%
American Century Companies
113
American Century Companies
Missouri
$340K -$77.7K -3,332 -20%
State Board of Administration of Florida Retirement System
114
State Board of Administration of Florida Retirement System
Florida
$336K +$9.56K +410 +3%
Calamos Advisors
115
Calamos Advisors
Illinois
$329K +$302K +12,937 New
ProShare Advisors
116
ProShare Advisors
Maryland
$301K +$28K +1,201 +11%
Walleye Trading
117
Walleye Trading
New York
$278K +$255K +10,937 New
Arrowstreet Capital
118
Arrowstreet Capital
Massachusetts
$270K +$247K +10,590 New
TI
119
Trexquant Investment
Connecticut
$268K +$246K +10,543 New
Connor, Clark & Lunn Investment Management (CC&L)
120
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$268K -$590K -25,280 -71%
Assenagon Asset Management
121
Assenagon Asset Management
Luxembourg
$255K -$236K -10,106 -50%
WS
122
Wedbush Securities
California
$255K – – –
Zurich Cantonal Bank
123
Zurich Cantonal Bank
Switzerland
$248K +$29.7K +1,272 +15%
Royal Bank of Canada
124
Royal Bank of Canada
Ontario, Canada
$241K +$137K +5,856 +162%
II
125
Inspire Investing
Idaho
$239K +$219K +9,378 New
3 4
5
6 7

SNDX Hedge Fund Activity: Q4 2022 in Review

160 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Syndax Pharmaceuticals (SNDX) for Q4 2022, worth a combined $1.78B — up 28% from $1.39B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SNDX positions and 10 closed out — a net gain of 22 holders — while 65 added to existing stakes and 41 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $83.9M. The largest seller was Woodline Partners, exiting entirely with an estimated $19M sold.

  • 160 institutional investors held Syndax Pharmaceuticals (SNDX) as of Q4 2022, up from 139 in Q3 2022.
  • Funds reported $1.78B of Syndax Pharmaceuticals stock for Q4 2022, up 28% quarter-over-quarter.
  • 32 funds opened new Syndax Pharmaceuticals positions in Q4 2022 and 10 closed out, a net change of +22 holders.
  • The largest Syndax Pharmaceuticals buyer in Q4 2022 was Wellington Management Group, an estimated $83.9M added.
  • The largest Syndax Pharmaceuticals seller in Q4 2022 was Woodline Partners, an estimated $19M sold.

Based on aggregated 13F filings for Q4 2022.